Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07817563
PHASE1

A Phase I Single Center Study Evaluating 68GA-FAPI-46 PET/CT in Patients With Interstitial Lung Disease

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this research is to better understand the distribution of an investigational radioactive imaging agent called 68Ga-FAPI-46 in the lungs of people with interstitial lung disease (ILD) during a Positron Emission Tomography/Computed Tomography (PET/CT) scan.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2026-10-16

Completion Date

2031-05

Last Updated

2026-09-14

Healthy Volunteers

No

Interventions

DRUG

⁶⁸Ga-FAPI-46

Subjects will have 68Ga-FAPI-46 intravenously administered

DIAGNOSTIC_TEST

PET/CT

Subjects will complete a PET/CT approximately 60-70 minutes after being given ⁶⁸Ga-FAPI-46

Locations (1)

Mayo Clinic

Rochester, Minnesota, United States